Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPX
1751
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $19.2M | ﹤0.01% |
527,559
+656
| +0.1% | +$21.6K |
|
1752
CVR Energy
CVI
$3.58B
| $19.1M | ﹤0.01% |
473,656
-10,481
| -2% | -$461K |
|
1753
Addus HomeCare
ADUS
$2.19B
| $19.1M | ﹤0.01% |
196,870
+15,956
| +9% | +$1.4M |
|
1754
AngioDynamics
ANGO
$647M
| $19.1M | ﹤0.01% |
1,193,773
-5,123
| -0.4% | -$78.2K |
|
1755
Greif
GEF
$5.03B
| $19.1M | ﹤0.01% |
432,128
-6,944
| -2% | -$287K |
|
1756
Lazard
LAZ
$4.43B
| $19.1M | ﹤0.01% |
477,955
-40,781
| -8% | -$1.54M |
|
1757
Hain Celestial
HAIN
$54.2M
| $19.1M | ﹤0.01% |
735,600
+7,701
| +1% | +$184K |
|
1758
Upbound Group
UPBD
$1.15B
| $19.1M | ﹤0.01% |
661,515
-112
| -0% | -$2.93K |
|
1759
Apollo Global Management
APO
$84.8B
| $19.1M | ﹤0.01% |
399,505
+393,030
| +6,070% | +$16.8M |
|
1760
Tennant Co
TNC
$1.15B
| $19M | ﹤0.01% |
244,447
-10,700
| -4% | -$797K |
|
1761
NETGEAR
NTGR
$647M
| $19M | ﹤0.01% |
775,406
-19,441
| -2% | -$531K |
|
1762
STAAR Surgical
STAA
$1.26B
| $19M | ﹤0.01% |
540,006
-42,680
| -7% | -$1.41M |
|
|
AVYA
1763
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $19M | ﹤0.01% |
1,406,496
+11,431
| +0.8% | +$140K |
|
1764
Moderna
MRNA
$25.4B
| $19M | ﹤0.01% |
970,665
+39,242
| +4% | +$696K |
|
1765
Mesa Laboratories
MLAB
$634M
| $19M | ﹤0.01% |
76,087
+540
| +0.7% | +$126K |
|
|
FFG
1766
DELISTED
FBL Financial Group
FFG
| $19M | ﹤0.01% |
321,926
-4,068
| -1% | -$234K |
|
1767
Caleres
CAL
$461M
| $18.9M | ﹤0.01% |
796,757
-24,732
| -3% | -$559K |
|
1768
MaxLinear
MXL
$6.95B
| $18.9M | ﹤0.01% |
888,780
-35,506
| -4% | -$737K |
|
1769
Pediatrix Medical
MD
$2.14B
| $18.8M | ﹤0.01% |
678,020
+22,356
| +3% | +$561K |
|
|
MNTV
1770
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $18.8M | ﹤0.01% |
1,053,823
-12,983
| -1% | -$228K |
|
1771
Nomura Holdings
NMR
$29.2B
| $18.8M | ﹤0.01% |
3,644,343
+44,093
| +1% | +$213K |
|
1772
Enerpac Tool Group
EPAC
$1.89B
| $18.8M | ﹤0.01% |
721,683
-51,741
| -7% | -$1.26M |
|
|
IRBT
1773
DELISTED
iRobot
IRBT
| $18.8M | ﹤0.01% |
370,840
-9,555
| -3% | -$480K |
|
|
AVLR
1774
DELISTED
Avalara, Inc.
AVLR
| $18.8M | ﹤0.01% |
256,153
-56,886
| -18% | -$4.13M |
|
|
TSE
1775
DELISTED
Trinseo
TSE
| $18.7M | ﹤0.01% |
503,152
-24,255
| -5% | -$985K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.